Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240589 · ClinicalTrials.gov registry record · NA
Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02240589 is a NA study that has completed, run by Indiana University. The registered enrollment target is 11 participants.
The verdict
NCT02240589, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if memantine can improve cognitive and neuropsychiatric outcomes after severe traumatic brain injury.
Interventions
- DRUG Placebo
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02240589
The ClinicalTrials.gov registry entry for NCT02240589 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02240589 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02240589 about?
NCT02240589 is a clinical study titled "Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury". The purpose of this study is to determine if memantine can improve cognitive and neuropsychiatric outcomes after severe traumatic brain injury.
What is the current status of trial NCT02240589?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-12. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02240589?
The interventions under investigation include: Placebo (DRUG), Memantine (DRUG).
Who is sponsoring clinical trial NCT02240589?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.